Pluri Inc. Reports Increased Revenue but Significant Rise in Net Losses for Six Months Ending December 31, 2025

Pluri Inc. reported its financial results for the six months ending December 31, 2025, revealing a slight increase in revenue but a significant rise in net losses compared to the same period in the previous year. The company generated revenues of $514,000 for the six-month period, up from $511,000 in the prior year. For the three-month period ending December 31, 2025, revenues reached $198,000, compared to $185,000 in the same quarter of 2024. However, the cost of revenues also increased, leading to a gross profit of $201,000 for the six-month period, down from $311,000 a year earlier.

The company's net loss for the six months ending December 31, 2025, was $13,004,000, compared to a loss of $9,146,000 for the same period in 2024. This increase in losses is attributed to higher research and development expenses, which rose by 33% to $7,757,000, and general and administrative expenses, which increased by 14% to $5,300,000. The rise in expenses was primarily due to increased salaries and share-based compensation, as well as costs associated with the acquisition of Kokomodo, a majority-owned subsidiary focused on sustainable cacao production.

In terms of operational developments, Pluri Inc. has made strategic moves to enhance its market position. The company launched its PluriCDMO™ division, which offers cell therapy manufacturing services, and has signed several agreements with clients in this area. Additionally, Pluri completed the acquisition of approximately 79% of Kokomodo, which aims to revolutionize cacao production through cellular agriculture. The company also reported a significant increase in its employee headcount, reflecting its expansion efforts.

Pluri's financial position remains challenging, with total current assets of $13,804,000 and current liabilities of $32,346,000 as of December 31, 2025, resulting in a working capital deficit of $18,542,000. The company has an accumulated deficit of $455,448,000 and is actively seeking additional liquidity to support its operations and research activities. Management has indicated that they have sufficient resources to meet operating obligations for less than six months, raising concerns about the company's ability to continue as a going concern.

Looking ahead, Pluri Inc. anticipates that it will not generate significant revenues from product sales in the next twelve months. The company is focused on securing additional capital, entering into commercial partnerships, and continuing its research and development activities. However, there are no assurances that it will be able to obtain the necessary financing, which could lead to a scaling down or discontinuation of operations if liquidity issues persist.